# BEPOTASTINE BESILATE
> **ANDA206066** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2019-03-05
## Drug
- **FDA Application Number:** ANDA206066
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BEPOTASTINE BESILATE
- **Generic name:** Bepotastine Besilate
- **Active ingredients:** BEPOTASTINE BESILATE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2019-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206066)
---
*AI Analytics · CC0 1.0*